循环hsa-miR-210-3p作为原发性开角型青光眼潜在生物标志物的发现与验证
本研究纳入136例原发性开角型青光眼(POAG)患者和对照,通过RNA测序和qRT-PCR发现hsa-miR-210-3p在POAG患者中升高,ROC分析显示其区分POAG与对照的AUC在筛选集为0.846、验证集为0.813,在重度POAG与对照中AUC为0.880,且其表达与视野平均缺损绝对值和平均视网膜神经纤维层厚度相关。
要点
- hsa-miR-210-3p在POAG患者中升高,筛选集AUC 0.846(敏感度84.6%,特异度80.8%)。
- 验证集AUC 0.813(敏感度84.8%,特异度69.7%);重度POAG与对照AUC 0.880(敏感度85.4%,特异度85.7%)。
- hsa-miR-210-3p表达与视野平均缺损绝对值(β=0.237;P=0.022)和平均视网膜神经纤维层厚度(β=-5.792;P=0.014)相关。
核心结论
- 循环hsa-miR-210-3p可能作为POAG的潜在诊断标志物,尤其对重度POAG患者。
研究设计与样本
- 研究纳入136例POAG患者和对照,采用下一代RNA测序探索循环miRNA表达谱,并用qRT-PCR在筛选集和验证集的独立样本中验证候选miRNA。
主要发现
- 测序和qRT-PCR显示hsa-miR-210-3p在所有集中POAG患者均升高。
- 筛选集ROC分析:hsa-miR-210-3p区分POAG与匹配对照的AUC为0.846(敏感度84.6%,特异度80.8%)。
- 验证集ROC分析:hsa-miR-210-3p区分POAG与匹配对照的AUC为0.813(敏感度84.8%,特异度69.7%)。
- 所有非测序参与者分析:hsa-miR-210-3p区分重度POAG与对照的AUC为0.880(敏感度85.4%,特异度85.7%)。
- hsa-miR-210-3p表达与视野平均缺损绝对值(β=0.237;P=0.022)和平均视网膜神经纤维层厚度(β=-5.792;P=0.014)相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Blood-based examination tools for glaucoma diagnosis in clinical practice, which can be useful for screening patients when traditional ophthalmic examinations cannot be utilized, are not available thus far. This study aimed to identify circulating microRNAs (miRNAs) associated with primary open-angle glaucoma (POAG) and explore their utility as diagnostic markers. METHODS: A total of 136 POAG patients and controls were enrolled. Next-generation RNA sequencing was used to explore the expression profile of circulating miRNAs in the sequencing set, and potential miRNAs from independent samples in both the screening and validation sets were validated by quantitative real-time polymerase chain reaction (qRT-PCR). Receiver operating characteristic (ROC) analysis was used to evaluate the ability of certain miRNAs to distinguish POAG patients from control subjects. RESULTS: Using sequencing and qRT-PCR, hsa-miR-210-3p was found to be elevated in POAG patients in all sets. ROC analysis of the screening and validation sets revealed that hsa-miR-210-3p differentiated between POAG patients and matched controls with an area under the curve (AUC) of 0.846 (sensitivity: 84.6%; specificity: 80.8%) and 0.813 (sensitivity: 84.8%; specificity: 69.7%), respectively. In case of all nonsequencing participants, analysis revealed that hsa-miR-210-3p differentiated between severe POAG patients and controls with an AUC of 0.880 (sensitivity: 85.4%; specificity: 85.7%). In addition, the expression of hsa-miR-210-3p was associated with visual field defects of |mean deviation| (β = 0.237; P = 0.022) and average retinal nerve fiber layer thickness (β = -5.792; P = 0.014). CONCLUSIONS: Circulating hsa-miR-210-3p may serve as a potential diagnostic marker for POAG (especially for severe POAG patients).
引用
- Liu Y, Wang Y, Chen Y, et al. Discovery and Validation of Circulating Hsa-miR-210-3p as a Potential Biomarker for Primary Open-Angle Glaucoma. Invest Ophthalmol Vis Sci. 2019. PMID: 31284309. doi:10.1167/iovs.19-26663
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。